Jerrold Sendrow
Director/Board Member presso VIRPAX PHARMACEUTICALS, INC.
Patrimonio netto: 3 835 $ in data 31/03/2024
Profilo
Jerrold Sendrow is an Independent Director at Virpax Pharmaceuticals, Inc. since 2017.
Prior to this, he was a Director at SCILEX Pharmaceuticals, Inc. from 2014 to 2016.
He worked as an Accountant-Audit Departments at Peat Marwick Mitchell & Co. and as Head-Accountant at Touche Ross & Co. He also worked as an Accountant-Audit Departments at Touche Ross & Co. (Australia).
Mr. Sendrow completed his undergraduate degree from Adelphi University and Baruch College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 22/03/2024 | 900 ( 0.08% ) | 3 835 $ | 31/03/2024 |
Posizioni attive di Jerrold Sendrow
| Società | Posizione | Inizio |
|---|---|---|
| VIRPAX PHARMACEUTICALS, INC. | Director/Board Member | 01/01/2017 |
Precedenti posizioni note di Jerrold Sendrow
| Società | Posizione | Fine |
|---|---|---|
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Director/Board Member | 01/11/2016 |
| Touche Ross & Co. | Comptroller/Controller/Auditor | - |
| Touche Ross & Co. (Australia) | Comptroller/Controller/Auditor | - |
| Peat Marwick Mitchell & Co. | Comptroller/Controller/Auditor | - |
Formazione di Jerrold Sendrow
| Adelphi University | Undergraduate Degree |
| Baruch College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VIRPAX PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Health Technology |
| Peat Marwick Mitchell & Co. | Commercial Services |
| Touche Ross & Co. | Commercial Services |
| Touche Ross & Co. (Australia) |
- Borsa valori
- Insiders
- Jerrold Sendrow
